Drug
Beam 103
Beam 103: highest development phase Phase 1, developed by Beam Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Beam Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| BEAM-103 NCT07304791 | Phase 1 | Healthy Subjects |
Latest
No recent events.
Follow Beam 103 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.